| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/03/2003 | EP1250418A4 Methods for identifying anti-cancer drug targets |
| 09/03/2003 | EP1230343A4 Aspegillus niger beta-glucosidase gene, protein and uses thereof |
| 09/03/2003 | EP1144620B1 Magnetic particles for purifying nucleic acids |
| 09/03/2003 | EP1086178B1 An anthraquinone and its derivatives |
| 09/03/2003 | EP1027433B1 Human app or a4ct sequences encoding the mutation i45f |
| 09/03/2003 | EP1023309B1 High surface density covalent immobilization of oligonucleotide monolayers |
| 09/03/2003 | EP0991456B1 One step device and process for concentration and purification of biological molecules |
| 09/03/2003 | EP0973391A4 Endoderm, cardiac and neural inducing factors |
| 09/03/2003 | EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc |
| 09/03/2003 | EP0857210B1 Therapeutic antiangiogenic compositions and methods |
| 09/03/2003 | EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4 |
| 09/03/2003 | EP0828844B1 Promoters for gene expression |
| 09/03/2003 | EP0769555B1 Gene coding for glycosyltransferase and use thereof |
| 09/03/2003 | EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 09/03/2003 | EP0763116B1 Recombinant viruses, preparation and use thereof in gene therapy |
| 09/03/2003 | EP0757994B1 Tcf mutant |
| 09/03/2003 | EP0744028B1 Highly specific surfaces for biological reactions, method of preparation and utilization |
| 09/03/2003 | EP0743988B1 Method for ordering macromolecules by means of a moving meniscus, and uses thereof |
| 09/03/2003 | EP0739417B1 Production of l-isoleucine by means of recombinant micro-organisms with deregulated threonine dehydratase |
| 09/03/2003 | EP0711349B1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 09/03/2003 | EP0673425B1 Dna encoding chitin deacetylase |
| 09/03/2003 | EP0660874B1 Recombinant dnase b derived from streptococcus pyogenes |
| 09/03/2003 | EP0647273B1 Dna sequences encoding oligosaccharide transporter |
| 09/03/2003 | EP0607297B1 Hormone analogs with multiple ctp extensions |
| 09/03/2003 | CN1440462A Method of identifying and producing antigen peptides and use thereof as vaccines |
| 09/03/2003 | CN1440459A Expression system |
| 09/03/2003 | CN1440458A Nucleotide sequences coding for MDHA gene |
| 09/03/2003 | CN1440456A Sentinel virus Ôàí" |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440423A Immunoadhesin for the prevention of rhinovirus infection |
| 09/03/2003 | CN1440420A Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 09/03/2003 | CN1440296A Vaccine against foot-and-mouth disease |
| 09/03/2003 | CN1439719A Human gene ZNF382 related to heart growth |
| 09/03/2003 | CN1439651A Recombined human CD11a monoclone antibody and its preparation and medicinal composition |
| 09/03/2003 | CN1439647A Saltant dihydrofolic acid reductase gene and application in mammal cell gene expression thereof |
| 09/03/2003 | CN1439646A Method for segregating nucleic acid |
| 09/03/2003 | CN1439645A Nucleotide with O-antigen idiocrasy against Ball's and shiga's-8 and colibacillus 0143 |
| 09/03/2003 | CN1120240C Plant virus resistance conferring polyribozyme and resistant plants producing same |
| 09/03/2003 | CN1120235C Alkaline protease deficient filamentous fungi |
| 09/03/2003 | CN1119933C Insect control method with genetically engineered biopesticides |
| 09/02/2003 | US6613962 Given DNA sequence; insect resistance |
| 09/02/2003 | US6613961 Cell containing a DNA molecule comprising a promoter, cytochrome P450 monooxygenase gene and P450 reductase gene; use in detoxifying herbicides, poisons and extrinsic endocrine disruptors; bioremediation |
| 09/02/2003 | US6613960 Phloem-loading-specific promoter |
| 09/02/2003 | US6613959 Transgenic plants expressing a MAPKKK protein kinase domain |
| 09/02/2003 | US6613958 Genome comprising nucleotide sequence encoding a human matrix metalloproteinase and a fusion polypeptide; used for diagnosis and treatment of cartilage-degenerative disease |
| 09/02/2003 | US6613957 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals |
| 09/02/2003 | US6613956 Transgenic fly comprising a polynucleotide sequence under regulatory control of an eye specific promoter; phenotypic change in eye; can use for reducing cell death after trauma and treatment of cancer and diabetes |
| 09/02/2003 | US6613895 Forming a binding reaction by mixing sample with an insoluble silica matrix comprising particulate glass and a aqueous salt solution; separating; use for isolating plasmid DNA from cell lysates and DNA from agarose gels |
| 09/02/2003 | US6613892 Continuously expressing an inserted heterologous gene while remaining latent |
| 09/02/2003 | US6613891 Polynucleotides that encode bovine inhibin |
| 09/02/2003 | US6613884 Method for the removal/purification of serum albumins and means for use in the method |
| 09/02/2003 | US6613882 Use for intracellular transport and membrane presentation of certain epitopes |
| 09/02/2003 | US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines |
| 09/02/2003 | US6613877 Polypeptide for use in the diagnosis and treatment of osteoporosis, paget's disease, electrolyte, kidney and heart defects |
| 09/02/2003 | US6613787 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
| 09/02/2003 | US6613752 Using a Sleeping Beauty transposon system to integrate exogenous nucleic acid into the genome of at least one cell, i.e. a target cell, of a multicellular organism using vivo methods; includes a SB transposase; gene therapy; virus-free |
| 09/02/2003 | US6613751 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 09/02/2003 | US6613749 Papovavirus pseudocapsids and use thereof for exogenous material transfer |
| 09/02/2003 | US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents |
| 09/02/2003 | US6613744 BMP-6 proteins |
| 09/02/2003 | US6613735 Using quaternary ammonium compound |
| 09/02/2003 | US6613574 Method to identify interface residue in biomolecular complex |
| 09/02/2003 | US6613569 Inducible packaging cell lines for lentivirus vectors |
| 09/02/2003 | US6613567 Antisense inhibition of Her-2 expression |
| 09/02/2003 | US6613563 Viral vectors with modified tropism |
| 09/02/2003 | US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine |
| 09/02/2003 | US6613552 Microbe comprising enzyme-encoding recombinant DNA molecules and a inactivating mutation in at least one DNA molecule which encodes a shikimate kinase isozyme; culturing in presence of a carbon source |
| 09/02/2003 | US6613548 Fusion products containing insoluble proteinaceous tag |
| 09/02/2003 | US6613547 Nucleotides; signal sequences; DNA sequences; Saccharomyces; vectors/genetic/; yeasts; proteins; use of recombinant DNA containing transcription sequences in the production of proteins of interest |
| 09/02/2003 | US6613546 DNA; genomes; axons; exons; introns; splicing/genetic/; use to produce "useful protein" by animal cells transformed with expression vector comprised of nucleic acid encoding the "useful protein" and linked to DNA having promoter activity |
| 09/02/2003 | US6613545 Corynebacterium glutamicum; transport proteins; isoleucine; leucine; valine; nucleotide sequences; replication/genetic/; use to improve production of title amino acids for use in human medicine, pharmaceutical industry and animal nutrition |
| 09/02/2003 | US6613544 Osteoprotegerin |
| 09/02/2003 | US6613543 Fermentative carotenoid production |
| 09/02/2003 | US6613533 Histamine receptor |
| 09/02/2003 | US6613531 Detecting modulators of enzymes associated with transcriptional activities; obtain cells, incubate with modulators, monitor adjustment in enzyme activities |
| 09/02/2003 | US6613528 Microfibrillated cellulose used for screening of a biological compound and nucleic acids encoding it |
| 09/02/2003 | US6613527 Electrochemical denaturation of double-stranded nucleic acid |
| 09/02/2003 | US6613526 Contacting mixture of nucleic acid sequences with blood brain barrier or CSF-blood barrier tissue; partitioning increased affinity nucleic acids from candidate mixture; amplifying increased to yield a mixture of nucleic acids |
| 09/02/2003 | US6613522 Method of reconstituting a DNA library using RecA protein |
| 09/02/2003 | US6613521 Nucleic acids; CARD (Caspase Recruitment Domain) proteins; primers; hybridization probes; use in diagnosis, therapy for disorders from with abnormal levels of apoptotic cell death or abnormal activity of FAS/APO-1 or TNF receptor complexes |
| 09/02/2003 | US6613518 Quantitative measurement of gene expression based on isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| 09/02/2003 | US6613516 Preparation of nucleic acid samples |
| 09/02/2003 | US6613514 Evolving preferential protein; digest nuclelotide sequences substrate, join terminals, screen for preferential proteins, recover nucleotide sequences |
| 09/02/2003 | US6613511 Characterizing DNA |
| 09/02/2003 | US6613510 Detecting hybridization pattern of chromosomal probes in sample |
| 09/02/2003 | US6613506 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/02/2003 | US6613351 Vector including a complex between at least one compound having an amidine polar head of formula where m is 14 and at least one of nucleic acids molecules, polypeptides, glycosylated polypeptides and membrane |
| 09/02/2003 | US6613335 Provided are BASB011 polypeptides and polynucleotides encoding BASB011 polypeptide from Moraxella catarrhalis. Also provided are immunogenic uses. |
| 09/02/2003 | US6613333 Immunodominant human T-cell epitopes of hepatitis C virus |
| 09/02/2003 | US6613331 Vaccine against Lyme disease |
| 09/02/2003 | US6613323 Using esterase activity enzyme selected from pepper esterase and porcine esterase for protection of plant against phytopathogenic fuigi, protects plant against phytopathogenic fungi by inhibition of fungal appressorium formation |
| 09/02/2003 | US6613322 Administering enzyme inhibitors |
| 09/02/2003 | US6613321 Strain is unable to express homologous O-polysaccharide due to a 1.2 kb deletion that spans the junction of the rfbA and rfbB genes, and expresses a heterologous O-polysaccharide that is covalently linked to a lipopolysaccharide |
| 09/02/2003 | US6613320 Recombinant CD4+ T cells from an individual afflicted with hyper IgM syndrome transformed with vectors carrying either the wild type or the mutagenized CD40Ls, metabolically radiolabeled, and examined for expression |
| 09/02/2003 | US6613319 Long-term expression of erythropoietin and growth hormone by transforming muscle cells |
| 09/02/2003 | CA2110516C Intersexual heterozygous phycomyces |
| 08/28/2003 | WO2003071281A2 Estrogen receptor interaction with a transcription factor |
| 08/28/2003 | WO2003071270A2 Screening method |
| 08/28/2003 | WO2003071268A2 Method for discovering pharmacologically active substances |
| 08/28/2003 | WO2003071267A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors |